Activation of eNOS by polyphenol-rich products and polyphenolic compounds

Current Pharmaceutical Design

Volumn 20, Issue 22, 2014, Pages 3521-3529

  Kim, Jong Hun ^a   Auger, Cyril ^a   Schini Kerth, Valérie B ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Endothelial function; Endothelial NO synthase; Nitric oxide; Polyphenol; Red wine

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; POLYPHENOL; POLYPHENOL DERIVATIVE; NITRIC OXIDE;

ARTICLE; BERRY; BIOLOGICAL ACTIVITY; CARDIOVASCULAR DISEASE; CELL FUNCTION; DRUG BIOAVAILABILITY; ENDOTHELIUM CELL; ENZYME ACTIVATION; GRAPE; HUMAN; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TEA; VASCULAR ENDOTHELIUM; BIOSYNTHESIS; CARDIOVASCULAR DISEASES; DRUG EFFECTS; ENZYMOLOGY; METABOLISM;

CARDIOVASCULAR DISEASES; ENDOTHELIAL CELLS; HUMANS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; POLYPHENOLS;

EID: 84925883827     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/13816128113196660751     Document Type: Article

References (119)

1. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373-6.
2. Yetik-Anacak G, Catravas JD. Nitric oxide and the endothelium: History and impact on cardiovascular disease. Vasc Pharmacol 2006; 45: 268-76.
3. Vanhoutte PM, Boulanger CM. Endothelium-dependent responses in hypertension. Hypertens Res 1995; 18: 87-98.
4. Lerman A, Zeiher AM. Endothelial Function. Circulation 2005; 111: 363-368.
5. Deanfield JE, Halcox JP, Rabelink TJ. Endothelial Function and Dysfunction. Circulation 2007; 115: 1285-95.
6. Vanhoutte PM, Shimokawa H, Tang EHC, Feletou M. Endothelial dysfunction and vascular disease. Acta Physiol 2009; 196: 193-222.
7. Kane MO, Etienne-Selloum N, Madeira SV, et al. Endothelium-derived contracting factors mediate the Ang II-induced endothelial dysfunction in the rat aorta: preventive effect of red wine polyphenols. Pflug Arch Eur J Physiol 2010; 459: 671-9.
8. Dal-Ros S, Oswald-Mammosser M, Pestrikova T, et al. Losartan prevents portal hypertension-induced, redox-mediated endothelial dysfunction in the mesenteric artery in rats. Gastroenterology 2010; 138: 1574-84.
9. Dal-Ros S, Zoll J, Lang AL, et al. Chronic intake of red wine polyphenols by young rats prevents aging-induced endothelial dysfunction and decline in physical performance: role of NADPH oxidase. Biochem Biophys Res Commun 2011; 404: 743-9.
10. Idris Khodja N, Chataigneau T, Auger C, Schini-Kerth VB. Grape-derived polyphenols improve aging-related endothelial dysfunction in rat mesenteric artery: role of oxidative stress and the angiotensin system. PLoS One 2012; 7: e32039.
11. Sarr M, Chataigneau M, Martins S, et al. Red wine polyphenols prevent angiotensin II-induced hypertension and endothelial dysfunction in rats: role of NADPH oxidase. Cardiovasc Res 2006; 71: 794-802.
12. Dal-Ros S, Bronner C, Auger C, Schini-Kerth VB. Red wine polyphenols improve an established aging-related endothelial dysfunction in the mesenteric artery of middle-aged rats: role of oxidative stress. Biochem Biophys Res Commun 2012; 419: 381-7.
13. Virdis A, Ghiadoni L, Taddei S. Human endothelial dysfunction: EDCFs. Pflug Arch Eur J Physiol 2010; 459: 1015-23.
14. Yeboah J, Crouse JR, Hsu FC, Burke GL, Herrington DM. Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the Cardiovascular Health Study. Circulation 2007; 115: 2390-7.
15. Keys A. Coronary heart disease in seven countries. Circulation 1970; 41.
16. Renaud S, de Lorgeril M. Dietary lipids and their relation to ischaemic heart disease: from epidemiology to prevention. J Intern Med Suppl 1989; 731: 39-46.
17. Renaud S, de Lorgeril M, Delaye J, Guidollet J, Jacquard F, Mamelle N, Martin JL, Monjaud I, Salen P, Toubol P. Cretan Mediterranean diet for prevention of coronary heart disease. Am J Clin Nutr 1995; 61: 1360S-7S.
18. Renaud S, de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 1992; 339: 1523-6.
19. Sofi F, Cesari F, Abbate R, Gensini GF, Casini A. Adherence to Mediterranean diet and health status: meta-analysis. Brit Med J 2008; 337.
20. Mead A, Atkinson G, Albin D, et al. Dietetic guidelines on food and nutrition in the secondary prevention of cardiovascular disease-evidence from systematic reviews of randomized controlled trials (second update, January 2006). J Hum Nutr Diet 2006; 19: 401-9.
21. Serra-Majem L, Roman B, Estruch R. Scientific Evidence of Interventions Using the Mediterranean Diet: A Systematic Review. Nutr Rev 2006; 64: S27-S47.
22. Law MR, Morris JK. By how much does fruit and vegetable consumption reduce the risk of ischaemic heart disease? Eur J Clin Nutr 1998; 52: 549-56.
23. Dauchet L, Amouyel P, Hercberg S, Dallongeville J. Fruit and Vegetable Consumption and Risk of Coronary Heart Disease: A Meta-Analysis of Cohort Studies. J Nutr 2006; 136: 2588-2593.
24. He FJ, Nowson CA, MacGregor GA. Fruit and vegetable consumption and stroke: meta-analysis of cohort studies. Lancet 2006; 367: 320-6.
25. Di Castelnuovo A, Rotondo S, Iacoviello L, Donati MB, de Gaetano G. Meta-Analysis of Wine and Beer Consumption in Relation to Vascular Risk. Circulation 2002; 105: 2836-44.
26. Arts IC, Hollman PC, Feskens EJ, Bueno de Mesquita HB, Kromhout D. Catechin intake might explain the inverse relation between tea consumption and ischemic heart disease: the Zutphen Elderly Study. Am J Clin Nutr 2001; 74: 227-32.
27. Kuriyama S, Shimazu T, Ohmori K, et al. Green Tea Consumption and Mortality Due to Cardiovascular Disease, Cancer, and All Causes in Japan. JAMA-J Am Med Assoc 2006; 296: 1255-65.
28. Ding E, Hutfless S, Ding X, Girotra S. Chocolate and Prevention of Cardiovascular Disease: A Systematic Review. Nutr Metab 2006; 3: 2.
29. Hooper L, Kroon PA, Rimm EB, et al. Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2008; 88: 38-50.
30. Fitzpatrick DF, Hirschfield SL, Coffey RG. Endothelium-dependent vasorelaxing activity of wine and other grape products. Am J Physiol Heart Circ Physiol 1993; 265: H774-H778.
31. Burns J, Gardner PT, O'Neil J, et al. Relationship among antioxidant activity, vasodilation capacity, and phenolic content of red wines. J Agric Food Chem 2000; 48: 220-30.
32. Andriambeloson E, Kleschyov AL, Muller B, Beretz A, Stoclet JC, Andriantsitohaina R. Nitric oxide production and endothelium-dependent vasorelaxation induced by wine polyphenols in rat aorta. Brit J Pharmacol 1997; 120: 1053-8.
33. Cishek MB, Galloway MT, Karim M, German JB, Kappagoda CT. Effect of red wine on endothelium-dependent relaxation in rabbits. Clin Sci (Lond) 1997; 93: 507-11.
34. Fitzpatrick DF, Fleming RC, Bing B, Maggi DA, O'Malley RM. Isolation and characterization of endothelium-dependent vasorelaxing compounds from grape seeds. J Agric Food Chem 2000; 48: 6384-90.
35. Flesch M, Schwarz A, Bohm M. Effects of red and white wine on endothelium-dependent vasorelaxation of rat aorta and human coronary arteries. Am J Physiol Heart Circ Physiol 1998; 275: H1183-H1190.
36. Soares De MR, Costa Viana FS, Souza MA, et al. Antihypertensive, vasodilator and antioxidant effects of a vinifera grape skin extract. J Pharm Pharmacol 2002; 54: 1515-20.
37. Ndiaye M, Chataigneau T, Andriantsitohaina R, Stoclet JC, Schini-Kerth VB. Red wine polyphenols cause endothelium-dependent EDHF-mediated relaxations in porcine coronary arteries via a redox-sensitive mechanism. Biochem Biophys Res Commun 2003; 310: 371-7.
38. Anselm E, Chataigneau M, Ndiaye M, Chataigneau T, Schini-Kerth VB. Grape juice causes endothelium-dependent relaxation via a redox-sensitive Src-and Akt-dependent activation of eNOS. Cardiovasc Res 2007; 73: 404-13.
39. Madeira SV, Auger C, Anselm E, et al. eNOS activation induced by a polyphenol-rich grape skin extract in porcine coronary arteries. J Vasc Res 2009; 46: 406-16.
40. Ndiaye M, Chataigneau M, Lobysheva I, Chataigneau T, Schini-Kerth VB. Red wine polyphenol-induced, endothelium-dependent NO-mediated relaxation is due to the redox-sensitive PI3-kinase/Akt-dependent phosphorylation of endothelial NO-synthase in the isolated porcine coronary artery. FASEB J 2005; 19: 455-7.
41. Stoclet JC, Kleschyov A, Andriambeloson E, Diebolt M, Andriantsitohaina R. Endothelial no release caused by red wine polyphenols. J Physiol Pharmacol 1999; 50: 535-40.
42. Taubert D, Berkels R, Klaus W, Roesen R. Nitric oxide formation and corresponding relaxation of porcine coronary arteries induced by plant phenols: essential structural features. J Cardiovasc Pharm 2002; 40: 701-13.
43. Edirisinghe I, Burton-Freeman B, Tissa KC. Mechanism of the endothelium-dependent relaxation evoked by a grape seed extract. Clin Sci (Lond) 2008; 114: 331-7.
44. Auger C, Kim JH, Chabert P, et al. The EGCg-induced redox-sensitive activation of endothelial nitric oxide synthase and relaxation are critically dependent on hydroxyl moieties. Biochem Biophys Res Commun 2010; 393: 162-7.
45. Anselm E, Socorro VFM, Dal-Ros S, Schott C, Bronner C, Schini-Kerth VB. Crataegus Special Extract WS 1442 Causes Endothelium-dependent Relaxation via a Redox-sensitive Src-and Akt-dependent Activation of Endothelial NO Synthase but Not via Activation of Estrogen Receptors. J Cardiovasc Pharm 2009; 53: 253-260 10.1097/FJC.0b013e31819ccfc9.
46. Madeira SV, Auger C, Anselm E, et al. eNOS activation induced by a polyphenol-rich grape skin extract in porcine coronary arteries. J Vasc Res 2009; 46: 406-16.
47. Martin S, Andriambeloson E, Takeda K, Andriantsitohaina R. Red wine polyphenols increase calcium in bovine aortic endothelial cells: a basis to elucidate signalling pathways leading to nitric oxide production. Brit J Pharmacol 2002; 135: 1579-87.
48. Klinge CM, Blankenship KA, Risinger KE, et al. Resveratrol and estradiol rapidly activate MAPK signaling through estrogen receptors alpha and beta in endothelial cells. J Biol Chem 2005; 280: 7460-8.
49. Hien TT, Oh WK, Quyen BT, et al. Potent vasodilation effect of amurensin G is mediated through the phosphorylation of endothelial nitric oxide synthase. Biochem Pharmacol 2012; 84: 1437-50.
50. Kane MO, Anselm E, Rattmann YD, Auger C, Schini-Kerth VB. Role of gender and estrogen receptors in the rat aorta endothelium-dependent relaxation to red wine polyphenols. Vasc Pharmacol 2009; 51: 140-6.
51. Andriambeloson E, Magnier C, Haan-Archipoff G, et al. Natural dietary polyphenolic compounds cause endothelium-dependent vasorelaxation in rat thoracic aorta. J Nutr 1998; 128: 2324-33.
52. Auger C, Chaabi M, Anselm E, Lobstein A, Schini-Kerth VB. The red wine extract-induced activation of endothelial nitric oxide synthase is mediated by a great variety of polyphenolic compounds. Mol Nutr Food Res 2010; 54 Suppl 2: S171-83.
53. Leikert JF, Rathel TR, Wohlfart P, Cheynier V, Vollmar AM, Dirsch VM. Red wine polyphenols enhance endothelial nitric oxide synthase expression and subsequent nitric oxide release from endothelial cells. Circulation 2002; 106: 1614-7.
54. Wallerath T, Deckert G, Ternes T, et al. Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. Circulation 2002; 106: 1652-8.
55. Alhosin M, Anselm E, Rashid S, et al. Redox-Sensitive Up-Regulation of eNOS by Purple Grape Juice in Endothelial Cells: Role of PI3-Kinase/Akt, p38 MAPK, JNK, FoxO1 and FoxO3a. PLoS One 2013; 8: e57883.
56. Machha A, Mustafa MR. Chronic treatment with flavonoids prevents endothelial dysfunction in spontaneously hypertensive rat aorta. J Cardiovasc Pharm 2005; 46: 36-40.
57. Peng N, Clark JT, Prasain J, Kim H, White CR, Wyss JM. Antihypertensive and cognitive effects of grape polyphenols in estrogen-depleted, female, spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol 2005; 289: R771-R775.
58. de Moura RS, Miranda DZ, Pinto AC, et al. Mechanism of the endothelium-dependent vasodilation and the antihypertensive effect of Brazilian red wine. J Cardiovasc Pharm 2004; 44: 302-9.
59. Bernatova I, Pechanova O, Babal P, Kysela S, Stvrtina S, Andriantsitohaina R. Wine polyphenols improve cardiovascular remodeling and vascular function in NO-deficient hypertension. Am J Physiol Heart Circ Physiol 2002; 282: H942-H948.
60. Pechanova O, Bernatova I, Babal P, et al. Red wine polyphenols prevent cardiovascular alterations in L-NAME-induced hypertension. J Hypertens 2004; 22: 1551-9.
61. Jimenez R, Lopez-Sepulveda R, Kadmiri M, et al. Polyphenols restore endothelial function in DOCA-salt hypertension: role of endothelin-1 and NADPH oxidase. Free Radical Biol Med 2007; 43: 462-73.
62. Wang Z, Zou J, Cao K, Hsieh TC, Huang Y, Wu JM. Dealcoholized red wine containing known amounts of resveratrol suppresses atherosclerosis in hypercholesterolemic rabbits without affecting plasma lipid levels. Int J Mol Med 2005; 16: 533-40.
63. Arrick DM, Sun H, Patel KP, Mayhan WG. Chronic resveratrol treatment restores vascular responsiveness of cerebral arterioles in type 1 diabetic rats. Am J Physiol Heart Circ Physiol 2011; 301: H696-703.
64. Mladenka P, Zatloukalova L, Filipsky T, Hrdina R. Cardiovascular effects of flavonoids are not caused only by direct antioxidant activity. Free Radical Biol Med 2010; 49: 963-75.
65. Negishi H, Xu JW, Ikeda K, Njelekela M, Nara Y, Yamori Y. Black and green tea polyphenols attenuate blood pressure increases in stroke-prone spontaneously hypertensive rats. J Nutr 2004; 134: 38-42.
66. Ferrannini E, Cushman WC. Diabetes and hypertension: the bad companions. Lancet 2012; 380: 601-10.
67. Pende A, Dallegri F. Renin-angiotensin antagonists: therapeutic effects beyond blood pressure control? Curr Pharm Des 2012; 18: 1011-20.
68. Durante A, Peretto G, Laricchia A, et al. Role of the rennin-angiotensin-aldosterone system in the pathogenesis of atherosclerosis. Curr Pharm Des 2012; 18: 981-1004.
69. Jones ES, Black MJ, Widdop RE. Influence of Angiotensin II Subtype 2 Receptor (AT(2)R) Antagonist, PD123319, on Cardiovascular Remodelling of Aged Spontaneously Hypertensive Rats during Chronic Angiotensin II Subtype 1 Receptor (AT(1)R) Blockade. Int J Hypertens 2012; 2012: 543062.
70. Conti S, Cassis P, Benigni A. Aging and the renin-angiotensin system. Hypertension 2012; 60: 878-83.
71. Dal-Ros S, Bronner C, Schott C, et al. Angiotensin II-induced hypertension is associated with a selective inhibition of endothelium-derived hyperpolarizing factor-mediated responses in the rat mesenteric artery. J Pharmacol Exp Ther 2009; 328: 478-86.
72. Rajagopalan S, Kurz S, Munzel T, et al. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 1996; 97: 1916-23.
73. Miyazaki R, Ichiki T, Hashimoto T, I et al. SIRT1, a longevity gene, downregulates angiotensin II type 1 receptor expression in vascular smooth muscle cells. Arterioscl Throm Vas 2008; 28: 1263-9.
74. Agewall S, Wright S, Doughty RN, Whalley GA, Duxbury M, Sharpe N. Does a glass of red wine improve endothelial function? Eur Heart J 2000; 21: 74-8.
75. Djousse L, Ellison RC, McLennan CE, et al. Acute effects of a high-fat meal with and without red wine on endothelial function in healthy subjects. Am J Cardiol 1999; 84: 660-4.
76. Hashimoto M, Kim S, Eto M, et al. Effect of acute intake of red wine on flow-mediated vasodilatation of the brachial artery. Am J Cardiol 2001; 88: 1457-60.
77. Stein JH, Keevil JG, Wiebe DA, Aeschlimann S, Folts JD. Purple grape juice improves endothelial function and reduces the susceptibility of LDL cholesterol to oxidation in patients with coronary artery disease. Circulation 1999; 100: 1050-5.
78. Chou EJ, Keevil JG, Aeschlimann S, Wiebe DA, Folts JD, Stein JH. Effect of ingestion of purple grape juice on endothelial function in patients with coronary heart disease. Am J Cardiol 2001; 88: 553-5.
79. Albers AR, Varghese S, Vitseva O, Vita JA, Freedman JE. The Antiinflammatory Effects of Purple Grape Juice Consumption in Subjects with Stable Coronary Artery Disease. Arterioscl Throm Vas 2004; 24: e179-e180.
80. Park YK, Kim JS, Kang MH. Concord grape juice supplementation reduces blood pressure in Korean hypertensive men: double-blind, placebo controlled intervention trial. Biofactors 2004; 22: 145-7.
81. Lorenz M, Wessler S, Follmann E, et al. A constituent of green tea, epigallocatechin-3-gallate, activates endothelial nitric oxide synthase by a phosphatidylinositol-3-OH-kinase-, cAMP-dependent protein kinase-, and Akt-dependent pathway and leads to endothelial-dependent vasorelaxation. J Biol Chem 2004; 279: 6190-5.
82. Kim JA, Formoso G, Li Y, et al. Epigallocatechin gallate, a green tea polyphenol, mediates NO-dependent vasodilation using signaling pathways in vascular endothelium requiring reactive oxygen species and Fyn. J Biol Chem 2007; 282: 13736-45.
83. Anter E, Thomas SR, Schulz E, Shapira OM, Vita JA, Keaney JF, Jr. Activation of endothelial nitric-oxide synthase by the p38 MAPK in response to black tea polyphenols. J Biol Chem 2004; 279: 46637-43.
84. Anter E, Chen K, Shapira OM, Karas RH, Keaney JF, Jr. p38 mitogen-activated protein kinase activates eNOS in endothelial cells by an estrogen receptor alpha-dependent pathway in response to black tea polyphenols. Circ Res 2005; 96: 1072-8.
85. Li Y, Ying C, Zuo X, et al. Green tea polyphenols down-regulate caveolin-1 expression via ERK1/2 and p38MAPK in endothelial cells. J Nutr Biochem 2009; 20: 1021-7.
86. Schini-Kerth V, Auger C, Kim JH, Étienne-Selloum N, Chataigneau T. Nutritional improvement of the endothelial control of vascular tone by polyphenols: role of NO and EDHF. Pflug Arch Eur J Physiol 2010; 459: 853-62.
87. Roghani M, Baluchnejadmojarad T. Chronic epigallocatechin-gallate improves aortic reactivity of diabetic rats: underlying mechanisms. Vasc Pharmacol 2009; 51: 84-89.
88. Loke WM, Proudfoot JM, Hodgson JM, et al. Specific dietary polyphenols attenuate atherosclerosis in apolipoprotein E-knockout mice by alleviating inflammation and endothelial dysfunction. Arterioscl Throm Vas 2010; 30: 749-57.
89. Ihm SH, Jang SW, Kim OR, et al. Decaffeinated green tea extract improves hypertension and insulin resistance in a rat model of metabolic syndrome. Atherosclerosis 2012; 224: 377-83.
90. Ihm SH, Lee JO, Kim SJ, et al. Catechin prevents endothelial dysfunction in the prediabetic stage of OLETF rats by reducing vascular NADPH oxidase activity and expression. Atherosclerosis 2009; 206: 47-53.
91. Duffy SJ, Keaney Jr JF, Holbrook M, et al. Short-and Long-Term Black Tea Consumption Reverses Endothelial Dysfunction in Patients With Coronary Artery Disease. Circulation 2001; 104: 151-6.
92. Alexopoulos N, Vlachopoulos C, Aznaouridis K, et al. The acute effect of green tea consumption on endothelial function in healthy individuals. Eur J Cardiov Prev R 2008; 15: 300-5.
93. Widlansky ME, Hamburg NM, Anter E, et al. Acute EGCG supplementation reverses endothelial dysfunction in patients with coronary artery disease. J Am Coll Nutr 2007; 26: 95-102.
94. Oyama J, Maeda T, Kouzuma K, et al. Green tea catechins improve human forearm endothelial dysfunction and have antiatherosclerotic effects in smokers. Circ J 2010; 74: 578-88.
95. Mullen W, McGinn J, Lean MEJ, et al. Ellagitannins, Flavonoids, and Other Phenolics in Red Raspberries and Their Contribution to Antioxidant Capacity and Vasorelaxation Properties. J Agric Food Chem 2002; 50: 5191-6.
96. Auger C, Kim JH, Trinh S, Chataigneau T, Popken AM, Schini-Kerth VB. Fruit juice-induced endothelium-dependent relaxations in isolated porcine coronary arteries: evaluation of different fruit juices and purees and optimization of a red fruit juice blend. Food Funct 2011; 2: 245-50.
97. Edirisinghe I, Banaszewski K, Cappozzo J, McCarthy D, Burton-Freeman BM. Effect of Black Currant Anthocyanins on the Activation of Endothelial Nitric Oxide Synthase (eNOS) in vitro in Human Endothelial Cells. J Agric Food Chem 2011; 59: 8616-24.
98. Bell DR, Gochenaur K. Direct vasoactive and vasoprotective properties of anthocyanin-rich extracts. J Appl Physiol 2006; 100: 1164-70.
99. Edirisinghe I, Burton-Freeman B, Varelis P, Kappagoda T. Strawberry extract caused endothelium-dependent relaxation through the activation of PI3 kinase/Akt. J Agric Food Chem 2008; 56: 9383-90.
100. Yung LM, Tian XY, Wong WT, et al. Chronic cranberry juice consumption restores cholesterol profiles and improves endothelial function in ovariectomized rats. Eur J Nutr 2012.
101. Erlund I, Koli R, Alfthan G, Marniemi J, Puukka P, Mustonen P, Mattila P, Jula A. Favorable effects of berry consumption on platelet function, blood pressure, and HDL cholesterol. Am J Clin Nutr 2008; 87: 323-31.
102. Zhu Y, Xia M, Yang Y, et al. Purified anthocyanin supplementation improves endothelial function via NO-cGMP activation in hypercholesterolemic individuals. Clin Chem 2011; 57: 1524-33.
103. Naruszewicz M, aniewska I, Millo B, D u niewski M. Combination therapy of statin with flavonoids rich extract from chokeberry fruits enhanced reduction in cardiovascular risk markers in patients after myocardial infraction (MI). Atherosclerosis 2007; 194: e179-e184.
104. Simeonov SB, Botushanov NP, Karahanian EB, Pavlova MB, Husianitis HK, Troev DM. Effects of Aronia melanocarpa juice as part of the dietary regimen in patients with diabetes mellitus. Folia Med (Plovdiv) 2002; 44: 20-3.
105. Kulling SE, Rawel HM. Chokeberry (Aronia melanocarpa)-A Review on the Characteristic Components and Potential Health Effects. Planta Med 2008; 74: 1625-34.
106. Crozier A, Del Rio D, Clifford MN. Bioavailability of dietary flavonoids and phenolic compounds. Mol Aspects Med 2010; 31: 446-67.
107. Del Rio D, Rodriguez-Mateos A, Spencer JP, Tognolini M, Borges G, Crozier A. Dietary (Poly)phenolics in Human Health: Structures, Bioavailability, and Evidence of Protective Effects Against Chronic Diseases. Antioxid Redox Signal 2012.
108. Scalbert A, Williamson G. Dietary intake and bioavailability of polyphenols. J Nutr 2000; 130: 2073S-85S.
109. Basu A, Rhone M, Lyons TJ. Berries: emerging impact on cardiovascular health. Nutr Rev 2010; 68: 168-77.
110. Del Rio D, Borges G, Crozier A. Berry flavonoids and phenolics: bioavailability and evidence of protective effects. Brit J Nutr 2010; 104: S67-S90.
111. Manach C, Williamson G, Morand C, Scalbert A, Remesy C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 2005; 81: 230S-242S.
112. Manach C, Scalbert A, Morand C, Rémésy C, Jiménez L. Polyphenols: food sources and bioavailability. Am J Clin Nutr 2004; 79: 727-47.
113. Passamonti S, Vrhovsek U, Mattivi F. The interaction of anthocyanins with bilitranslocase. Biochem Biophys Res Commun 2002; 296: 631-6.
114. Aura AM, Martin-Lopez P, O’Leary KA, et al. In vitro metabolism of anthocyanins by human gut microflora. Eur J Nutr 2005; 44: 133-42.
115. Vitaglione P, Donnarumma G, Napolitano A, Galvano F, Gallo A, Scalfi L, Fogliano V. Protocatechuic Acid Is the Major Human Metabolite of Cyanidin-Glucosides. J Nutr 2007; 137: 2043-8.
116. Tsang C, Auger C, Mullen W, et al. The absorption, metabolism and excretion of flavan-3-ols and procyanidins following the ingestion of a grape seed extract by rats. Brit J Nutr 2005; 94: 170-81.
117. Calani L, Del Rio D, Luisa Callegari M, Morelli L, Brighenti F. Updated bioavailability and 48 h excretion profile of flavan-3-ols from green tea in humans. Int J Food Sci Nutr 2012; 63: 513-21.
118. D'Archivio M, Filesi C, Di Benedetto R, Gargiulo R, Giovannini C, Masella R. Polyphenols, dietary sources and bioavailability. Ann Ist Super Sanità 2007; 43: 348-61.
119. Kawai Y, Nishikawa T, Shiba Y, et al. Macrophage as a target of quercetin glucuronides in human atherosclerotic arteries: implication in the anti-atherosclerotic mechanism of dietary flavonoids. J Biol Chem 2008; 283: 9424-34.